|
ABCF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74189999979646E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57990999999358E-05 |
| Normal-vs-Stage2 |
2.346400E-02 |
| Normal-vs-Stage3 |
6.24510000379885E-08 |
| Normal-vs-Stage4 |
8.477400E-03 |
| Stage1-vs-Stage2 |
9.085000E-01 |
| Stage1-vs-Stage3 |
6.904200E-02 |
| Stage1-vs-Stage4 |
5.812200E-01 |
| Stage2-vs-Stage3 |
3.059200E-01 |
| Stage2-vs-Stage4 |
8.012200E-01 |
| Stage3-vs-Stage4 |
8.140200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09250000046579E-07 |
| Normal-vs-AfricanAmerican |
2.76799999998634E-06 |
| Normal-vs-Asian |
4.536000E-01 |
| Caucasian-vs-AfricanAmerican |
3.863200E-01 |
| Caucasian-vs-Asian |
2.279400E-01 |
| AfricanAmerican-vs-Asian |
1.960390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.87520000030739E-07 |
| Normal-vs-Female |
3.58249999999893E-05 |
| Male-vs-Female |
4.766400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.662100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.50440000001861E-06 |
| Normal-vs-Age(61-80Yrs) |
2.15089999999751E-06 |
| Normal-vs-Age(81-100Yrs) |
4.160500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.579400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.381000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.920800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.990400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.098800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.223600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.946000E-01 |
| Normal-vs-Grade 2 |
2.90599999996921E-06 |
| Normal-vs-Grade 3 |
3.85999999741315E-08 |
| Normal-vs-Grade 4 |
1.814300E-02 |
| Grade 1-vs-Grade 2 |
6.762400E-01 |
| Grade 1-vs-Grade 3 |
5.043400E-01 |
| Grade 1-vs-Grade 4 |
8.717200E-01 |
| Grade 2-vs-Grade 3 |
2.775400E-01 |
| Grade 2-vs-Grade 4 |
5.122200E-01 |
| Grade 3-vs-Grade 4 |
1.994010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.04290000005436E-06 |
| Normal-vs-ccB subtype |
1.404560E-04 |
| ccA subtype-vs-ccB subtype |
6.550000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79191999999384E-05 |
| Normal-vs-N1 |
6.475000E-01 |
| N0-vs-N1 |
4.693000E-01 |
|
|
